Literature DB >> 5673190

Hepatic artery and celiac axis infusion for the treatment of upper abdominal malignant lesions.

G W Wirtanen, L C Bernhardt, S Mackman, G Ramirez, A R Curreri, F J Ansfield.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5673190      PMCID: PMC1387198          DOI: 10.1097/00000658-196807000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  5 in total

1.  A REPORT UPON ARTERIAL INFUSION WITH 5-FLUOROURACIL IN 100 PATIENTS.

Authors:  R O JOHNSON; W A KISKEN; A R CURRERI
Journal:  Surg Gynecol Obstet       Date:  1965-03

2.  Five years clinical experience with 5-fluorouracil.

Authors:  F J ANSFIELD; J M SCHROEDER; A R CURRERI
Journal:  JAMA       Date:  1962-07-28       Impact factor: 56.272

3.  Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.

Authors:  R D SULLIVAN; E MILLER; M P SIKES
Journal:  Cancer       Date:  1959 Nov-Dec       Impact factor: 6.860

4.  Effects of intra-arterial administration of nitrogen mustard.

Authors:  H R BIERMAN; R L BYRON; E R MILLER; M B SHIMKIN
Journal:  Am J Med       Date:  1950-04       Impact factor: 4.965

5.  An evaluation of 51 patients with hepatic artery infusion.

Authors:  D B Rochlin; C R Smart
Journal:  Surg Gynecol Obstet       Date:  1966-09
  5 in total
  2 in total

1.  One shot administration of antineoplastic agents in massive doses via the celiac artery for inoperable cancer of the liver.

Authors:  Y Kinami; M Hirose; O Takamatu
Journal:  Jpn J Surg       Date:  1972-09

2.  Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy.

Authors:  Roi Anteby; Nancy E Kemeny; T Peter Kingham; Michael I D'Angelica; Alice C Wei; Vinod P Balachandran; Jeffrey A Drebin; Murray F Brennan; Leslie H Blumgart; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2020-12-30       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.